advertisement

WGW-2018

11.13 Combination therapy (18)

Showing records 1 to 18

Display only abstracts from IGR 18-3 in classification 11.13 Combination therapy

Search within classification 11.13 Combination therapy

71233 Impact of Combination Glaucoma Therapies on β-Blocker Exposure
Xu K; Campbell EL; Gill SS; Nesdole R; Campbell RJ
Journal of Glaucoma 2017; 26: e107-e109 (IGR: 18-3)


65831 New drugs and preparations for open-angle glaucoma in adults

Drug and therapeutics bulletin 2015; 53: 141-144 (IGR: 17-3)


58738 Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice
Holló G; Topouzis F; Fechtner RD
Expert Opinion in Pharmacotherapy 2014; 15: 1737-1747 (IGR: 16-3)


52604 Combination therapy in the medical treatment of glaucoma
Hommer A
Klinische Monatsblätter für Augenheilkunde 2013; 230: 133-140 (IGR: 15-1)


51335 Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis
Cheng JW; Cheng SW; Gao LD; Lu GC; Wei RL
PLoS ONE 2012; 7: e45079 (IGR: 14-3)


50518 Combination therapy as initial treatment in glaucoma and suspected glaucoma
Mikelberg FS; Etminan M
Canadian Journal of Ophthalmology 2012; 47: 240-242 (IGR: 14-2)


47689 Progress of anti-glaucoma fixed combination formulation
Yang YF; Yu MB
Chinese Journal of Ophthalmology 2011; 47: 176-180 (IGR: 13-4)


46262 Control of intraocular pressure fluctuation: Are combination drugs more effective?
Feldman RM; Bell NP; Nagi KS
Expert Review of Ophthalmology 2011; 6: 151-154 (IGR: 13-2)


28183 Role of fixed combinations in the management of open-angle glaucoma
Hommer A
Expert Review of Pharmacoeconomics and Outcomes Research 2011; 11: 91-99 (IGR: 13-1)


25888 Considerations in glaucoma therapy: Fixed combinations versus their component medications
Higginbotham EJ
Clinical Ophthalmology 2010; 4: 1-9 (IGR: 12-2)


24595 The effects of combination glaucoma medications on ocular surface epithelial cells
Ammar DA; Kahook MY
Advances in Therapy 2009; 1-6 (IGR: 11-4)


24579 Glaucoma medication persistence with a fixed combination versus multiple bottles
Higginbotham EJ; Hansen J; Davis EJ; Walt JG; Guckian A
Current Medical Research and Opinion 2009; 25: 2543-2547 (IGR: 11-4)


24056 Ophthalmologist attitudes regarding fixed combination treatment for glaucoma in the European Union
Stewart WC; Kruft B; Nelson LA; Stewart JA
European Journal of Ophthalmology 2009; 19: 588-593 (IGR: 11-3)


23545 Fixed combinations of glaucoma medications
Calugaru D; Calugaru M
Oftalmologia 2008; 52: 23-31 (IGR: 11-2)


21498 Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs
Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
Biological & Pharmaceutical Bulletin 2008; 31: 1590-1595 (IGR: 10-3)


21327 Efficacy of antiglaucoma fixed combination therapy versus unfixed components in reducing intraocular pressure: A systematic review
Cox JA; Mollan SP; Bankart J; Robinson R
British Journal of Ophthalmology 2008; 92: 729-734 (IGR: 10-2)


20322 The costs of treating glaucoma with combinations of topical drugs in Spain
Neymark N; Buchholz P; Honrubia F; Kobelt G
European Journal of Ophthalmology 2008; 18: 52-59 (IGR: 10-1)


19787 Use of fixed-dose combination drugs for the treatment of glaucoma
Khouri AS; Realini T; Fechtner RD
Drugs and Aging 2007; 24: 1007-1016 (IGR: 9-4)



Issue 18-3

Select Issue


advertisement

Octopus

advertisement

WGW-2018